Result of AGM

Synairgen plc
15 November 2005


PRESS RELEASE
--------------------------                                 ---------------------

                                 SYNAIRGEN PLC
                         ('Synairgen' or the 'Company')
                                 RESULT OF AGM

Synairgen, the drug discovery company focused on identifying the underlying
causes of, and treatments for, asthma and  chronic obstructive pulmonary disease
(COPD) is pleased to announce that all the resolutions at the Annual General 
Meeting of the Company, held earlier today, 15 November 2005, were duly passed.

                                     -Ends-

For further information, please contact:

Synairgen                                                   Tel: [phone]
Richard Marsden, Managing Director

Hogarth Partnership                                         Tel: [phone]
Melanie Toyne-Sewell / Georgina Briscoe




                      This information is provided by RNS
            The company news service from the London Stock Exchange